ゲノム編集/ゲノム工学市場

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2021年11月

ゲノム編集/ゲノム工学市場: テクノロジー(CRISPR、TALEN、ZFN、アンチセンス)、製品とサービス、用途(細胞株工学、遺伝子工学、診断)、エンドユーザー(製薬、バイオテクノロジー、学界)-2026年までの世界予測

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics), End user (Pharmaceutical, Biotechnology, Academia) – Global Forecast to 2026

ページ数 201
図表数 235
種別 英文調査報告書

目次  お問合せ

The global genome editing/genome engineering market is expected to reach USD 11.7 billion by 2026 from USD 5.1 billion in 2021, at a CAGR of 18.2% during the forecast period. The growth of the genome editing/genome engineering market is expected to be driven by the rise in government funding and growth in the number of genomics projects, increased application areas of genomics, and the introduction of CRISPR-Cas9 for genome engineering.

“The services segment accounted for the highest growth rate in the genome editing/genome engineering market, by product & service, during the forecast period”
In 2020, the services segment accounted for the highest growth rate. The genomic editing/genome engineering services market is segmented into sequencing services; data analysis; bioinformatics services; and other services, such as informatics, clean up, gene expression, and DNA synthesis services. Most companies in the services sector offer all these services. Although the services segment represents a major part of the market, some end users have in-house sequencing and bioinformatics capabilities. Service providers possess highly advanced and multiple sequencing platforms and make use of high-quality consumables/kits. They also have multiple sequencing platforms, which enables these service providers to choose the most appropriate system to solve the scientific challenges of their customers and promptly deliver high-quality sequencing at a low cost.

“The CRISPR segment accounted for the largest share of the application segment, by technology, in the genome editing/genome engineering”
In 2020, the CRISPR technology accounted for the largest share. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is a revolutionary tool used to edit genes in a way that resembles traditional GMO techniques. The use of the Cas9 enzymes differentiates CRISPR from other forms of genetic modification. The ease of use associated with CRISPR technology gives it a significant advantage over ZFN and TALEN, especially in generating a large set of vectors to target numerous sites or even genome-wide libraries. Another potential advantage of CRISPR is its ability to use multiple guide RNA parallelly to target multiple sites simultaneously in the same cell. This makes it easier to mutate multiple genes at once or engineer precise deletions in a genomic region.

“Asia Pacific: The fastest-growing region in the genome editing/genome engineering market”
The genome editing/genome engineering market is segmented into North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA). Increasing government support, and developing R&D infrastructure Increasing investments in research and rising number of applications of gene synthesis for genetic engineering of cells and tissues of organisms are the major factors fueling the growth of the genome editing/genome engineering market in the Asia Pacific region.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: C-level – 55%, D-level – 20%, and Others – 25%
• By Region: North America -50%, Europe -20%, Asia-Pacific -20%, RoW -10%
List of Companies Profiled in the Report:
• Thermo Fisher Scientific (US)
• Merck KGaA (Germany)
• GenScript China)
• Sangamo Therapeutics (US)
• Lonza (Switzerland)
• Editas medicine (US)
• CRISPR Therapeutics
• Tecan Life sciences (Switzerland)
• Precision biosciences (US)
• Agilent technologies (Switzerland)
• PerkinElmer (US)
• Cellectis SA (France)
• Intellia Therapeutics (US)
• Bluebird Bio (US)
• Regeneron Pharmaceuticals (US)
• Synthego (US)
• Vigene Biosciences (US)
• Beam Therapeutics (US)
• Integrated DNA Technologies (US)
• New England Biolabs (US)
• Origene Technologies (US)
• Transposagen Biopharmaceuticals (US)
• Creative Biogene (US)
• Recombinetics (US)
• Caribou Biosciences (US)
Research Coverage:
This report provides a detailed picture of the genome editing/genome engineering market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall genome editing/genome engineering market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, challenges, trends, and opportunities.


目次

1 INTRODUCTION 31
1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS & EXCLUSIONS 31
1.3 MARKET SCOPE 32
1.3.1 MARKETS COVERED 32
1.3.2 YEARS CONSIDERED FOR THE STUDY 32
1.4 CURRENCY 33
1.5 LIMITATIONS 33
1.6 STAKEHOLDERS 33
1.7 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 1 RESEARCH DESIGN 35
2.1.1 SECONDARY DATA 36
2.1.2 PRIMARY DATA 36
FIGURE 2 BREAKDOWN OF PRIMARIES: GENOME EDITING/GENOME ENGINEERING MARKET 37
2.2 MARKET ESTIMATION METHODOLOGY 37
FIGURE 3 GENOME EDITING/GENOME ENGINEERING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2020 37
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2020 38
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 39
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 39
2.3 MARKET GROWTH RATE PROJECTIONS 40
FIGURE 6 GENOME EDITING/GENOME ENGINEERING MARKET (SUPPLY-SIDE): CAGR PROJECTIONS 40
FIGURE 7 GENOME EDITING/GENOME ENGINEERING MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS 41
2.4 DATA TRIANGULATION 42
FIGURE 8 DATA TRIANGULATION METHODOLOGY 42
2.5 RESEARCH ASSUMPTIONS 42
2.5.1 COVID-19 SPECIFIC ASSUMPTIONS 43
2.6 RISK ANALYSIS 43
3 EXECUTIVE SUMMARY 44
FIGURE 9 GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION) 44
FIGURE 10 GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY
2021 VS. 2026 (USD MILLION) 45
FIGURE 11 GENOME EDITING/GENOME ENGINEERING, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 45
FIGURE 12 GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER
2021 VS. 2026 (USD MILLION) 46
FIGURE 13 GEOGRAPHICAL SNAPSHOT: GENOME EDITING/GENOME ENGINEERING MARKET 47
4 PREMIUM INSIGHTS 48
4.1 GENOME EDITING/GENOME ENGINEERING MARKET OVERVIEW 48
FIGURE 14 GROWING INVESTMENTS IN GENOMICS RESEARCH TO DRIVE MARKET GROWTH 48
4.2 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING SHARE, BY PRODUCT & SERVICE AND COUNTRY (2020) 49
FIGURE 15 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE GENOME EDITING/GENOME ENGINEERING MARKET IN NORTH AMERICA IN 2020 49
4.3 GENOME EDITING/GENOME ENGINEERING SHARE, BY TECHNOLOGY (2020) 49
FIGURE 16 THE CRISPR SEGMENT ACCOUNTED FOR THE LARGEST SHARE IN THE GENOME EDITING/GENOME ENGINEERING MARKET IN 2020 49
4.4 GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 50
FIGURE 17 THE CELL LINE ENGINEERING SEGMENT EXPECTED TO DOMINATE THE APPLICATIONS MARKET IN 2026 50
4.5 GENOME EDITING/GENOME ENGINEERING MARKET SHARE, BY END USER, 2020 50
FIGURE 18 THE PHARMACEUTICAL COMPANIES SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020 50
4.6 GENOME EDITING/GENOME ENGINEERING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 51
FIGURE 19 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE GENOME EDITING/GENOME ENGINEERING MARKET FROM 2021 TO 2026 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
FIGURE 20 GENOME EDITING/GENOME ENGINEERING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGE 52
TABLE 1 GENOME EDITING/GENOME ENGINEERING MARKET: IMPACT ANALYSIS 53
5.2.1 DRIVERS 53
5.2.1.1 Rise in government funding and growth in the number of genomics projects 53
5.2.1.2 Increased application areas of genomics 54
5.2.1.3 Introduction of CRISPR-Cas9 54
5.2.2 RESTRAINTS 54
5.2.2.1 Off-target effects of CRISPR technology 54
5.2.3 OPPORTUNITIES 55
5.2.3.1 Extensive use of genome editing in personalized medicine 55
5.2.3.2 High growth prospects for the market in emerging countries 55
5.2.4 CHALLENGES 55
5.2.4.1 High equipment costs 55
5.3 RANGES/SCENARIOS 56
FIGURE 21 SPECTRUM OF SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES ON THE GROWTH OF THE GENOME EDITING/GENOME ENGINEERING MARKET 56
5.4 IMPACT OF COVID-19 OUTBREAK ON THE GENOME EDITING/GENOME ENGINEERING MARKET 56
FIGURE 22 GENOME EDITING/GENOME ENGINEERING SCENARIO WITH AND WITHOUT COVID-19 IMPACT. 2019-2021 57
5.5 TRENDS/DISRUPTIONS IMPACTING BUSINESSES OF CUSTOMERS 58
5.6 VALUE CHAIN ANALYSIS 59
FIGURE 23 VALUE CHAIN ANALYSIS OF THE GENOME EDITING/GENOME ENGINEERING MARKET: RESEARCH AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE 59
5.7 TECHNOLOGICAL ANALYSIS 60
5.8 PATENT ANALYSIS 61
FIGURE 24 PATENT APPLICATIONS FOR GENETIC ENGINEERING MARKET, JANUARY 2011–OCTOBER 2021 61
TABLE 2 INDICATIVE LIST OF PATENTS IN THE GENOME EDITING/GENOME ENGINEERING MARKET 62
5.9 ECOSYSTEM ANALYSIS OF THE GENOME EDITING/GENOME ENGINEERING MARKET 62
FIGURE 25 ECOSYSTEM ANALYSIS OF THE GENOME EDITING/GENOME ENGINEERING MARKET 62
TABLE 3 SUPPLY CHAIN ECOSYSTEM 63
5.10 PORTER’S FIVE FORCES ANALYSIS 64
TABLE 4 GENOME EDITING/ GENOME ENGINEERING MARKET: PORTER’S FIVE FORCES ANALYSIS 64
5.10.1 THREAT OF NEW ENTRANTS 64
5.10.2 THREAT OF SUBSTITUTES 64
5.10.3 BARGAINING POWER OF SUPPLIERS 65
5.10.4 BARGAINING POWER OF BUYERS 65
5.10.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 65
5.11 REGULATORY ANALYSIS 65
5.11.1 REGULATIONS FOR PRODUCTS DEVELOPED USING GENOME EDITING/GENOME ENGINEERING TECHNOLOGY 65
5.11.1.1 US 65
TABLE 5 REGULATIONS FOR PRODUCTS DEVELOPED USING GENOME EDITING/GENOME ENGINEERING TECHNIQUES 66
5.11.1.2 China 66
6 GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE 68
6.1 INTRODUCTION 69
TABLE 6 GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 69
6.2 REAGENTS & CONSUMABLES 69
6.2.1 REAGENTS & CONSUMABLES HOLD THE LARGEST MARKET SHARE 69
TABLE 7 GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION) 69
TABLE 8 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 70
TABLE 9 EUROPE: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 70
TABLE 10 APAC: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 70
TABLE 11 LATAM: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION) 71
6.3 SOFTWARE & SYSTEMS 71
6.3.1 RISING APPLICATION OF GENOME EDITING/SEQUENCING TO INCREASE THE DEMAND FOR SYSTEMS AND SOFTWARE 71
TABLE 12 GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 71
TABLE 13 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 72
TABLE 14 EUROPE: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 72
TABLE 15 APAC: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 72
TABLE 16 LATAM: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 73
6.4 SERVICES 73
6.4.1 WIDE APPLICATION OF EDITING/GENOME ENGINEERING SERVICES TO INCREASE MARKET GROWTH 73
TABLE 17 GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 73
TABLE 18 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 74
TABLE 19 EUROPE: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 74
TABLE 20 APAC: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 74
TABLE 21 LATAM: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 75
7 GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY 76
7.1 INTRODUCTION 77
TABLE 22 GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 77
7.2 CRISPR 77
7.2.1 EASE OF USE GIVES CRISPR AN ADVANTAGE OVER OTHER TECHNOLOGIES 77
TABLE 23 GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY REGION, 2019–2026 (USD MILLION) 78
TABLE 24 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY COUNTRY, 2019–2026 (USD MILLION) 78
TABLE 25 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY COUNTRY, 2019–2026 (USD MILLION) 78
TABLE 26 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY COUNTRY, 2019–2026 (USD MILLION) 79
TABLE 27 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY REGION, 2019–2026 (USD MILLION) 79
7.3 TALEN 79
7.3.1 QUICK MODIFICATIONS IN THE GENOME SEQUENCE ARE POSSIBLE WITH TALEN 79
TABLE 28 GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY REGION, 2019–2026 (USD MILLION) 80
TABLE 29 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY COUNTRY, 2019–2026 (USD MILLION) 80
TABLE 30 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY COUNTRY, 2019–2026 (USD MILLION) 80
TABLE 31 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY COUNTRY, 2019–2026 (USD MILLION) 81
TABLE 32 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY REGION, 2019–2026 (USD MILLION) 81
7.4 ZFN 81
7.4.1 EUKARYOTE CELL STUDIES DONE BY ZFN TO DRIVE MARKET GROWTH 81
TABLE 33 GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY REGION, 2019–2026 (USD MILLION) 82
TABLE 34 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2018–2025 (USD MILLION) 82
TABLE 35 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2019–2026 (USD MILLION) 82
TABLE 36 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2019–2026 (USD MILLION) 83
TABLE 37 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY REGION, 2019–2026 (USD MILLION) 83
7.5 ANTISENSE 83
7.5.1 INCREASED APPLICATION IN ENGINEERING HUMAN CELLS FOR DISEASE STUDY TO DRIVE MARKET GROWTH 83
TABLE 38 GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY REGION, 2019–2026 (USD MILLION) 84
TABLE 39 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY COUNTRY, 2019–2026 (USD MILLION) 84
TABLE 40 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY COUNTRY, 2019–2026 (USD MILLION) 84
TABLE 41 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY COUNTRY, 2019–2026 (USD MILLION) 85
TABLE 42 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY REGION, 2019–2026 (USD MILLION) 85
7.6 OTHER TECHNOLOGIES 85
TABLE 43 GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2019–2026 (USD MILLION) 86
TABLE 44 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2019–2026 (USD MILLION) 86
TABLE 45 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2019–2026 (USD MILLION) 86
TABLE 46 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2019–2026 (USD MILLION) 87
TABLE 47 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2019–2026 (USD MILLION) 87
8 GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION 88
8.1 INTRODUCTION 89
TABLE 48 GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 89
8.2 CELL LINE ENGINEERING 89
8.2.1 INCREASING RESEARCH APPLICATIONS OF CELL LINE ENGINEERING TO PROMOTE MARKET GROWTH 89
TABLE 49 GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY REGION, 2019–2026 (USD MILLION) 90
TABLE 50 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2019–2026 (USD MILLION) 90
TABLE 51 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2019–2026 (USD MILLION) 90
TABLE 52 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2019–2026 (USD MILLION) 91
TABLE 53 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY REGION, 2019–2026 (USD MILLION) 91
8.3 GENETIC ENGINEERING 91
8.3.1 ANIMAL GENETIC ENGINEERING 91
8.3.1.1 Use of animal simulation models in research to increase the demand for genome editing 91
8.3.2 PLANT GENETIC ENGINEERING 92
8.3.2.1 Growing attention on GM crops will drive demand for genetic engineering in crops 92
TABLE 54 GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY REGION, 2019–2026 (USD MILLION) 92
TABLE 55 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2019–2026 (USD MILLION) 92
TABLE 56 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2019–2026 (USD MILLION) 93
TABLE 57 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2019–2026 (USD MILLION) 93
TABLE 58 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY REGION, 2019–2026 (USD MILLION) 93
8.4 DIAGNOSTIC APPLICATIONS 94
8.4.1 THE GROWING NUMBER OF APPLICATIONS IN DIAGNOSTICS WILL FAVOR MARKET GROWTH 94
TABLE 59 GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 94
TABLE 60 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 94
TABLE 61 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 95
TABLE 62 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 95
TABLE 63 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 95
8.5 DRUG DISCOVERY & DEVELOPMENT 96
8.5.1 GROWING RESEARCH AND APPLICATIONS IN DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET GROWTH 96
TABLE 64 GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2019–2026 (USD MILLION) 96
TABLE 65 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION) 97
TABLE 66 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION) 97
TABLE 67 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION) 97
TABLE 68 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2019–2026 (USD MILLION) 98
8.6 OTHER APPLICATIONS 98
TABLE 69 GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 98
TABLE 70 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 99
TABLE 71 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 99
TABLE 72 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 99
TABLE 73 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 100
9 GENOME EDITING/ GENOME ENGINEERING MARKET, BY END USER 101
9.1 INTRODUCTION 102
TABLE 74 GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER,
2019–2026 (USD MILLION) 102
9.2 PHARMACEUTICAL COMPANIES 102
9.2.1 CRISPR TECHNOLOGIES ARE USED BY PHARMACEUTICAL COMPANIES FOR APPLICATIONS IN GENE THERAPIES 102
TABLE 75 GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2019–2026 (USD MILLION) 102
TABLE 76 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 103
TABLE 77 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 103
TABLE 78 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 103
TABLE 79 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2019–2026 (USD MILLION) 104
9.3 BIOTECHNOLOGY COMPANIES 104
9.3.1 INCREASING IMPORTANCE OF BIOMARKERS TO DRIVE DEMAND FOR MARKET PRODUCTS IN BIOTECH COMPANIES 104
TABLE 80 GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION) 104
TABLE 81 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 105
TABLE 82 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 105
TABLE 83 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 105
TABLE 84 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION) 106
9.4 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES 106
9.4.1 TREND OF COLLABORATIVE RESEARCH WILL SUPPORT MARKET GROWTH 106
TABLE 85 GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION) 106
TABLE 86 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY,
2019–2026 (USD MILLION) 107
TABLE 87 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY,
2019–2026 (USD MILLION) 107
TABLE 88 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 107
TABLE 89 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION,
2019–2026 (USD MILLION) 108
10 GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION 109
10.1 INTRODUCTION 110
FIGURE 26 GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION 110
TABLE 90 GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION, 2019–2026 (USD MILLION) 110
10.2 NORTH AMERICA 111
FIGURE 27 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET SNAPSHOT 111
TABLE 91 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 112
TABLE 92 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 112
TABLE 93 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 112
TABLE 94 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 113
TABLE 95 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION) 113
10.2.1 US 113
10.2.1.1 The US dominates the North American market 113
TABLE 96 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 114
TABLE 97 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 114
TABLE 98 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 114
TABLE 99 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION) 115
10.2.2 CANADA 115
10.2.2.1 Availability of research funding in Canada drives the market growth 115
TABLE 100 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 116
TABLE 101 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 116
TABLE 102 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 116
TABLE 103 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION) 117
10.3 EUROPE 117
TABLE 104 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 117
TABLE 105 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 118
TABLE 106 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 118
TABLE 107 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 118
TABLE 108 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION) 119
10.3.1 GERMANY 119
10.3.1.1 Strong academic base and rising awareness are key growth drivers in Germany 119
TABLE 109 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 119
TABLE 110 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 120
TABLE 111 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 120
TABLE 112 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 USD MILLION) 120
10.3.2 UK 121
10.3.2.1 The UK is the largest market for genome engineering in Europe 121
TABLE 113 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 121
TABLE 114 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 121
TABLE 115 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 122
TABLE 116 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION) 122
10.3.3 FRANCE 122
10.3.3.1 Government funding for genomics and rising investments into research show potential for market growth 122
TABLE 117 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 123
TABLE 118 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 123
TABLE 119 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 123
TABLE 120 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION) 124
10.3.4 ITALY 124
10.3.4.1 Increasing collaborations are driving genomic medicine research, thus, boosting the gene editing market in Italy 124
TABLE 121 ITALY: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 125
TABLE 122 ITALY: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 125
TABLE 123 ITALY: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 125
TABLE 124 ITALY: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 USD MILLION) 126
10.3.5 SPAIN 126
10.3.5.1 Proactive research funding by the government to boost the market growth 126
TABLE 125 SPAIN: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 126
TABLE 126 SPAIN: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 127
TABLE 127 SPAIN: GENOME EDITING/GENOME ENGINEERING MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 127
TABLE 128 SPAIN: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 USD MILLION) 127
10.3.6 REST OF EUROPE 128
TABLE 129 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 128
TABLE 130 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 128
TABLE 131 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 129
TABLE 132 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION) 129
10.4 ASIA PACIFIC 130
FIGURE 28 APAC: GENOME EDITING/GENOME ENGINEERING MARKET SNAPSHOT 130
TABLE 133 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 131
TABLE 134 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 131
TABLE 135 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 131
TABLE 136 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 132
TABLE 137 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION) 132
10.4.1 CHINA 132
10.4.1.1 China to hold the largest share of the market in the Asia Pacific 132
TABLE 138 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 133
TABLE 139 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 133
TABLE 140 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 133
TABLE 141 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION) 134
10.4.2 JAPAN 134
10.4.2.1 Focus on cancer research showcases favorable scenarios for the market in Japan 134
TABLE 142 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 135
TABLE 143 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 135
TABLE 144 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 135
TABLE 145 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION) 136
10.4.3 INDIA 136
10.4.3.1 A growing number of startups and government support indicates growth potential 136
TABLE 146 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 136
TABLE 147 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 137
TABLE 148 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 137
TABLE 149 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION) 137
10.4.4 ROAPAC 138
10.4.4.1 The growth of the market in the RoAPAC is attributed to rising genomic Research 138
TABLE 150 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 138
TABLE 151 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 138
TABLE 152 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 139
TABLE 153 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION) 139
10.5 REST OF THE WORLD 139
10.5.1 LATAM 139
10.5.1.1 The growth of the market in the LATAM is attributed to rising research in genetically modified crops 139
TABLE 154 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION, 2019–2026 (USD MILLION) 140
TABLE 155 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 140
TABLE 156 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 140
TABLE 157 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 141
TABLE 158 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION) 141
10.5.1.2 Brazil 141
10.5.1.2.1 The rising number of workshops and conferences are increasing awareness, thus, promoting genome editing advancements 141
TABLE 159 BRAZIL: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 142
TABLE 160 BRAZIL: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 142
TABLE 161 BRAZIL: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 142
TABLE 162 BRAZIL: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION) 143
10.5.1.3 Rest of LATAM 143
10.5.1.3.1 Latin America is an attractive market for genomics 143
TABLE 163 REST OF LATAM: GENOME EDITING/GENOME ENGINEERING MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 143
TABLE 164 REST OF LATAM: GENOME EDITING/GENOME ENGINEERING MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 144
TABLE 165 REST OF LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 144
TABLE 166 REST OF LATAM: GENOME EDITING/GENOME ENGINEERING MARKET,
BY END USER, 2019–2026 (USD MILLION) 144
10.5.2 MIDDLE EAST & AFRICA 145
10.5.2.1 The rising prevalence of genomic disorders in the Middle East and the adoption of genetic testing are driving market growth 145
TABLE 167 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 145
TABLE 168 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 146
TABLE 169 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 146
TABLE 170 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019–2026 (USD MILLION) 146
11 COMPETITIVE LANDSCAPE 147
11.1 OVERVIEW 147
11.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN 147
FIGURE 29 KEY PLAYERS STRATEGIES IN THE GENOME EDITING/GENOME ENGINEERING MARKET, 2019- 2021 147
11.3 MARKET SHARE ANALYSIS 148
FIGURE 30 GENOME EDITING/GENOME ENGINEERING MARKET PLAYER RANKING, 2020 148
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 148
FIGURE 31 TOP MARKET PLAYERS DOMINATED THE GENOME EDITING/GENOME ENGINEERING MARKET IN THE LAST THREE YEARS 149
11.5 COMPANY EVALUATION QUADRANT 149
11.5.1 STARS 149
11.5.2 EMERGING LEADERS 149
11.5.3 PERVASIVE 150
11.5.4 EMERGING COMPANIES 150
FIGURE 32 GENOME EDITING/GENOME ENGINEERING MARKET: COMPANY EVALUATION QUADRANT, 2020 150
11.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES 151
11.6.1 PROGRESSIVE COMPANIES 151
11.6.2 STARTING BLOCKS 151
11.6.3 RESPONSIVE COMPANIES 151
11.6.4 DYNAMIC COMPANIES 151
FIGURE 33 GENOME EDITING/GENOME ENGINEERING MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020 152
11.7 COMPANY PRODUCT FOOTPRINT 153
TABLE 171 PRODUCT PORTFOLIO ANALYSIS: GENOME EDITING/GENOME ENGINEERING MARKET (2020) 153
11.8 COMPANY GEOGRAPHIC FOOTPRINT 154
TABLE 172 GEOGRAPHIC REVENUE MIX: GENOME EDITING/GENOME ENGINEERING MARKET (2020) 154
11.9 COMPETITIVE SCENARIO 155
11.9.1 SERVICE/ PRODUCT LAUNCHES 155
11.9.2 DEALS 156
11.9.3 OTHER DEVELOPMENTS 159
12 COMPANY PROFILES 160
12.1 KEY COMPANIES 160
(Business overview, Products & Services Offered, Recent developments, MNM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and competitive threats)*
12.1.1 THERMO FISHER SCIENTIFIC 160
TABLE 173 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 160
FIGURE 34 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020) 161
12.1.2 MERCK KGAA 164
TABLE 174 MERCK KGAA: BUSINESS OVERVIEW 164
FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2020) 164
12.1.3 GENSCRIPT 167
TABLE 175 GENSCRIPT: BUSINESS OVERVIEW 167
FIGURE 36 GENSCRIPT: COMPANY SNAPSHOT (2020) 168
12.1.4 SANGAMO THERAPEUTICS 171
TABLE 176 SANGAMO THERAPEUTICS: BUSINESS OVERVIEW 171
FIGURE 37 SANGAMO THERAPEUTICS: COMPANY SNAPSHOT (2020) 171
12.1.5 LONZA 173
TABLE 177 LONZA: BUSINESS OVERVIEW 173
FIGURE 38 LONZA: COMPANY SNAPSHOT (2020) 173
12.1.6 EDITAS MEDICINE 175
TABLE 178 EDITAS MEDICINE: BUSINESS OVERVIEW 175
FIGURE 39 EDITAS MEDICINE: COMPANY SNAPSHOT (2020) 175
12.1.7 CRISPR THERAPEUTICS AG 177
TABLE 179 CRISPR THERAPEUTICS AG: BUSINESS OVERVIEW 177
FIGURE 40 CRISPR THERAPEUTICS AG: COMPANY SNAPSHOT (2020) 177
12.1.8 TECAN LIFE SCIENCES 179
TABLE 180 TECAN LIFESCIENCES: BUSINESS OVERVIEW 179
FIGURE 41 TECAN LIFESCIENCES: COMPANY SNAPSHOT (2020) 180
12.1.9 PRECISION BIOSCIENCES 181
TABLE 181 PRECISION BIOSCIENCES: BUSINESS OVERVIEW 181
FIGURE 42 PRECISION BIOSCIENCES: COMPANY SNAPSHOT (2020) 181
12.1.10 AGILENT TECHNOLOGIES 183
TABLE 182 AGILENT TECHNOLOGIES: BUSINESS OVERVIEW 183
FIGURE 43 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2020) 184
12.1.11 PERKINELMER 186
TABLE 183 PERKINELMER: BUSINESS OVERVIEW 186
FIGURE 44 PERKINELMER: COMPANY SNAPSHOT (2020) 187
12.1.12 CELLECTIS S.A 189
TABLE 184 CELLECTIS S.A: BUSINESS OVERVIEW 189
FIGURE 45 CELLECTIS S.A: COMPANY SNAPSHOT (2020) 189
12.1.13 INTELLIA THERAPEUTICS 191
TABLE 185 INTELLIA THERAPEUTICS: BUSINESS OVERVIEW 191
FIGURE 46 INTELLIA THERAPEUTICS: COMPANY SNAPSHOT (2020) 191
12.1.14 BLUEBIRD BIO INC. 193
TABLE 186 BLUEBIRD BIO: BUSINESS OVERVIEW 193
FIGURE 47 BLUEBIRD BIO: COMPANY SNAPSHOT (2020) 193
12.1.15 REGENERON PHARMACEUTICALS INC. 195
TABLE 187 REGENERON PHARMACEUTICALS: BUSINESS OVERVIEW 195
FIGURE 48 REGENERON PHARMACEUTICALS: COMPANY SNAPSHOT (2020) 195
12.2 OTHER PLAYERS 197
12.2.1 SYNTHEGO CORPORATION 197
12.2.2 VIGENE BIOSCIENCES 197
12.2.3 BEAM THERAPEUTICS 198
12.2.4 INTEGRATED DNA TECHNOLOGIES 198
12.2.5 NEW ENGLAND BIOLABS 199
12.2.6 ORIGENE TECHNOLOGIES 199
12.2.7 TRANSPOSAGEN BIOPHARMACEUTICALS [HERA BIOLABS] 200
12.2.8 CREATIVE BIOGENE 200
12.2.9 RECOMBINETICS 201
12.2.10 CARIBOU BIOSCIENCES 201
*Details on Business overview, Products & Services Offered, Recent developments, MNM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX 202
13.1 DISCUSSION GUIDE 202
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 205
13.3 AVAILABLE CUSTOMIZATIONS 207
13.4 RELATED REPORTS 207
13.5 AUTHOR DETAILS 208


お問合せフォーム

    ※レポートのタイトルは自動で入ります。

    お名前(必須)

    会社名(必須)

    部署名

    メールアドレス(必須)

    電話番号

    当ウェブサイトを知った経由を教えてください。

    お問合せ区分(必須)

    お問合せ内容(必須)

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com